415 related articles for article (PubMed ID: 25315298)
1. The molecular targets of resveratrol.
Kulkarni SS; Cantó C
Biochim Biophys Acta; 2015 Jun; 1852(6):1114-23. PubMed ID: 25315298
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol and obesity: Can resveratrol relieve metabolic disturbances?
de Ligt M; Timmers S; Schrauwen P
Biochim Biophys Acta; 2015 Jun; 1852(6):1137-44. PubMed ID: 25446988
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation.
Lin JN; Lin VC; Rau KM; Shieh PC; Kuo DH; Shieh JC; Chen WJ; Tsai SC; Way TD
J Agric Food Chem; 2010 Feb; 58(3):1584-92. PubMed ID: 19928762
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol vs. calorie restriction: data from rodents to humans.
Lam YY; Peterson CM; Ravussin E
Exp Gerontol; 2013 Oct; 48(10):1018-24. PubMed ID: 23624181
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol reduces morphine tolerance by inhibiting microglial activation via AMPK signalling.
Han Y; Jiang C; Tang J; Wang C; Wu P; Zhang G; Liu W; Jamangulova N; Wu X; Song X
Eur J Pain; 2014 Nov; 18(10):1458-70. PubMed ID: 24756886
[TBL] [Abstract][Full Text] [Related]
6. Effect of resveratrol on mitochondrial function: implications in parkin-associated familiar Parkinson's disease.
Ferretta A; Gaballo A; Tanzarella P; Piccoli C; Capitanio N; Nico B; Annese T; Di Paola M; Dell'aquila C; De Mari M; Ferranini E; Bonifati V; Pacelli C; Cocco T
Biochim Biophys Acta; 2014 Jul; 1842(7):902-15. PubMed ID: 24582596
[TBL] [Abstract][Full Text] [Related]
7. Metabolic benefits from Sirt1 and Sirt1 activators.
Chaudhary N; Pfluger PT
Curr Opin Clin Nutr Metab Care; 2009 Jul; 12(4):431-7. PubMed ID: 19474719
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological activation of AMPK ameliorates perivascular adipose/endothelial dysfunction in a manner interdependent on AMPK and SIRT1.
Sun Y; Li J; Xiao N; Wang M; Kou J; Qi L; Huang F; Liu B; Liu K
Pharmacol Res; 2014 Nov; 89():19-28. PubMed ID: 25108154
[TBL] [Abstract][Full Text] [Related]
9. Lifespan and healthspan extension by resveratrol.
Bhullar KS; Hubbard BP
Biochim Biophys Acta; 2015 Jun; 1852(6):1209-18. PubMed ID: 25640851
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol induces Sirt1-dependent apoptosis in 3T3-L1 preadipocytes by activating AMPK and suppressing AKT activity and survivin expression.
Chen S; Xiao X; Feng X; Li W; Zhou N; Zheng L; Sun Y; Zhang Z; Zhu W
J Nutr Biochem; 2012 Sep; 23(9):1100-12. PubMed ID: 22137261
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol induces cell apoptosis in adipocytes via AMPK activation.
Chen S; Zhou N; Zhang Z; Li W; Zhu W
Biochem Biophys Res Commun; 2015 Feb; 457(4):608-13. PubMed ID: 25603053
[TBL] [Abstract][Full Text] [Related]
12. Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases.
Zordoky BN; Robertson IM; Dyck JR
Biochim Biophys Acta; 2015 Jun; 1852(6):1155-77. PubMed ID: 25451966
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol inhibits lipogenesis of 3T3-L1 and SGBS cells by inhibition of insulin signaling and mitochondrial mass increase.
Li S; Bouzar C; Cottet-Rousselle C; Zagotta I; Lamarche F; Wabitsch M; Tokarska-Schlattner M; Fischer-Posovszky P; Schlattner U; Rousseau D
Biochim Biophys Acta; 2016 Jun; 1857(6):643-52. PubMed ID: 26968895
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure.
Gu XS; Wang ZB; Ye Z; Lei JP; Li L; Su DF; Zheng X
Genet Mol Res; 2014 Jan; 13(1):323-35. PubMed ID: 24535859
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol--a boon for treating Alzheimer's disease?
Anekonda TS
Brain Res Rev; 2006 Sep; 52(2):316-26. PubMed ID: 16766037
[TBL] [Abstract][Full Text] [Related]
16. Sirtuin activators.
Alcaín FJ; Villalba JM
Expert Opin Ther Pat; 2009 Apr; 19(4):403-14. PubMed ID: 19441923
[TBL] [Abstract][Full Text] [Related]
17. Sirtuins: novel targets for metabolic disease in drug development.
Jiang WJ
Biochem Biophys Res Commun; 2008 Aug; 373(3):341-4. PubMed ID: 18577374
[TBL] [Abstract][Full Text] [Related]
18. Effects of resveratrol in patients with type 2 diabetes mellitus on skeletal muscle SIRT1 expression and energy expenditure.
Goh KP; Lee HY; Lau DP; Supaat W; Chan YH; Koh AF
Int J Sport Nutr Exerc Metab; 2014 Feb; 24(1):2-13. PubMed ID: 23918588
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol and related compounds as antioxidants with an allosteric mechanism of action in epigenetic drug targets.
Farghali H; Kutinová Canová N; Lekić N
Physiol Res; 2013; 62(1):1-13. PubMed ID: 23173686
[TBL] [Abstract][Full Text] [Related]
20. Metabolic effects of resveratrol in mammals--a link between improved insulin action and aging.
Fröjdö S; Durand C; Pirola L
Curr Aging Sci; 2008 Dec; 1(3):145-51. PubMed ID: 20021385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
